Evidence map›Paper›PMID 35013270›Full record

ArticleNature communications2022

Oxylipin metabolism is controlled by mitochondrial β-oxidation during bacterial inflammation.

Mariya Misheva, Konstantinos Kotzamanis, Luke C Davies, Victoria J Tyrrell, Patricia R S Rodrigues, Gloria A Benavides, Christine Hinz, Robert C Murphy, Paul Kennedy, Philip R Taylor and 14 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. 12/15-lipoxygenase orchestrates murine wound healing via PPARγ-activating oxylipins acting holistically to dampen inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. ACAD10 and ACAD11 enable mammalian 4-hydroxy acid lipid catabolism.Nature structural & molecular biology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 4 countries.

Mariya MishevaSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
Konstantinos Kotzamanis *Systems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.ORCID http://orcid.org/0000-0002-6846-7761
Luke C Davies *Systems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
Victoria J TyrrellSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
Patricia R S RodriguesSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.ORCID http://orcid.org/0000-0003-0768-0013
Gloria A BenavidesDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Christine HinzSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
Robert C MurphyDepartment of Pharmacology, University of Colorado Denver, Aurora, CO, 80045, USA.
Paul KennedyCayman Chemical, 1180 E Ellsworth Rd, Ann Arbor, MI, 48108, USA.
Philip R TaylorSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.ORCID http://orcid.org/0000-0003-0163-1421
Marcela RosasSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
Simon A JonesSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
James E McLarenSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.ORCID http://orcid.org/0000-0002-7021-5934
Sumukh DeshpandeSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
Robert AndrewsSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
Nils Helge SchebbChair of Food Chemistry, Faculty of Mathematics and Natural Sciences, University of Wuppertal, Gausstraße 20, 42119, Wuppertal, Germany.
Magdalena A CzubalaSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
Mark GurneySystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.ORCID http://orcid.org/0000-0003-1119-6638
Maceler AldrovandiSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
Sven W MeckelmannSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.
Peter GhazalSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK.ORCID http://orcid.org/0000-0003-0035-2228
Victor Darley-UsmarDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Daniel A WhiteSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK. WhiteD13@cardiff.ac.uk.ORCID http://orcid.org/0000-0002-7588-8935
Valerie B O'DonnellSystems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, CF14 4XN, Cardiff, UK. o-donnellvb@cardiff.ac.uk.ORCID http://orcid.org/0000-0003-4089-8460
Cardiff University · GBUniversity of Alabama at Birmingham · USCayman Chemical (United States) · USInstitute of Infection and Immunity · CAUK Dementia Research Institute · GBUniversity of Colorado Denver · USUniversity of Wuppertal · DE

Funding

Biotechnology and Biological Sciences Research Council BB/T009543/1Medical Research Council MR/X00077X/1Versus Arthritis 20770Wellcome Trust
6 · The paper itself

Abstract

Oxylipins are potent biological mediators requiring strict control, but how they are removed en masse during infection and inflammation is unknown. Here we show that lipopolysaccharide (LPS) dynamically enhances oxylipin removal via mitochondrial β-oxidation. Specifically, genetic or pharmacological targeting of carnitine palmitoyl transferase 1 (CPT1), a mitochondrial importer of fatty acids, reveal that many oxylipins are removed by this protein during inflammation in vitro and in vivo. Using stable isotope-tracing lipidomics, we find secretion-reuptake recycling for 12-HETE and its intermediate metabolites. Meanwhile, oxylipin β-oxidation is uncoupled from oxidative phosphorylation, thus not contributing to energy generation. Testing for genetic control checkpoints, transcriptional interrogation of human neonatal sepsis finds upregulation of many genes involved in mitochondrial removal of long-chain fatty acyls, such as ACSL1,3,4, ACADVL, CPT1B, CPT2 and HADHB. Also, ACSL1/Acsl1 upregulation is consistently observed following the treatment of human/murine macrophages with LPS and IFN-γ. Last, dampening oxylipin levels by β-oxidation is suggested to impact on their regulation of leukocyte functions. In summary, we propose mitochondrial β-oxidation as a regulatory metabolic checkpoint for oxylipins during inflammation.

Indexed as

12-Hydroxy-5,8,10,14-eicosatetraenoic AcidAcyl-CoA Dehydrogenase, Long-ChainAnimalsCarnitine O-PalmitoyltransferaseCoenzyme A LigasesFemaleGene Expression RegulationHumansInfant, NewbornInterferon-gammaLipid MetabolismLipidomicsLipopolysaccharidesLong-Chain-Fatty-Acid-CoA LigaseMacrophagesMale12-Hydroxy-5,8,10,14-eicosatetraenoic AcidACADVL protein, humanACSL1 protein, humanAcyl-CoA Dehydrogenase, Long-ChainCarnitine O-PalmitoyltransferaseCoenzyme A LigasesCPT1B protein, humanHADHB protein, humanInterferon-gammaLipopolysaccharidesLong-Chain-Fatty-Acid-CoA LigaseMitochondrial Trifunctional Protein, beta SubunitOxylipins

Identifiers

PMID35013270
PMCPMC8748967
OpenAlexW4206046220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.